Eric Swalwell鈥檚 Tweet About Georgia鈥檚 New Abortion Restriction Only Slightly Off-Key
The claim by Democratic presidential candidate Eric Swalwell is correct but could use more context and clarification.
The independent source for health policy research, polling, and news.
601-620 of 1,004 results
The claim by Democratic presidential candidate Eric Swalwell is correct but could use more context and clarification.
A talking point used by House Speaker Nancy Pelosi refers to all three of these distinct concepts in a way that could magnify public misperceptions.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
Joanne Kenen of Politico, Jen Haberkorn of the Los Angeles Times and Alice Miranda Ollstein of Politico join KHN鈥檚 Julie Rovner to discuss the latest news about the Trump administration鈥檚 effort to allow health care practitioners and organizations to refuse to provide care or refer patients for services that violate their conscience or religion. Also this week, the administration orders TV ads for prescription drugs to include list prices. And Tennessee wants free rein from the federal government to run its Medicaid program. Plus, Rovner interviews Joan Biskupic, author of a new book on Chief Justice John Roberts, about the behind-the-scenes negotiations that led to the 2012 ruling upholding the constitutionality of the Affordable Care Act.
During a hearing Tuesday, panel members focused on how drug companies have used patents to allegedly protect their competitive edge and profits.
Giving consumers more knowledge about the costs of care has long been desired, but administration officials cautioned it could take two years or more for useful data to appear in a phone app.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
In an unusual move, the House Rules Committee, instead of one of the panels that typically oversee health policy, held the first House hearing in a decade about converting the U.S. to a government-financed health care system.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
The pesticide chlorpyrifos has been linked to developmental problems in children. Some state and federal lawmakers want the chemical banned, but federal regulators are fighting to keep it on the market.
Alice Miranda Ollstein of Politico, Kimberly Leonard of the Washington Examiner and Rebecca Adams of CQ Roll Call join KHN鈥檚 Julie Rovner to discuss the latest news about women鈥檚 reproductive health policy and the latest skirmish in the debate over 鈥淢edicare-for-all鈥�: how hospitals should be paid.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
Jennifer Haberkorn of the Los Angeles Times, Joanne Kenen of Politico and Kimberly Leonard of the Washington Examiner join KHN鈥檚 Julie Rovner to answer listener questions about the fate of the Affordable Care Act, 鈥淢edicare-for-all鈥� and how to talk about health care costs. Also, for extra credit, the panelists offer their favorite 鈥渆xtra credit鈥� stories of the week.
Julie Rovner of Kaiser Health News talks about the court case challenging the Affordable Care Act and Democratic proposals to expand Medicare on C-SPAN and NPR.
The plan by Sanders has drawn a lot of attention on the campaign trail and Capitol Hill.聽聽
Sarah Kliff of Vox.com, Margot Sanger-Katz of The New York Times and Paige Winfield Cunningham of The Washington Post join KHN鈥檚 Julie Rovner to discuss the latest version of a 鈥淢edicare-for-all鈥� bill by Sen. Bernie Sanders (I-Vt.), a presidential hopeful, and Democratic and Republican reactions to it. They also discuss the latest on congressional efforts to rein in drug prices and another state effort to expand Medicaid 鈥� but not exactly in the way voters wanted. Also, Rovner interviews Ceci Connolly of the Alliance of Community Health Plans.
During Wednesday鈥檚 House subcommittee hearing on insulin price hikes, drug makers and benefits managers pointed fingers at each other for the last decade鈥檚 300% price increase, frustrating congressional representatives.
The Senate Finance Committee鈥檚 third drug-pricing hearing focused on pharmacy benefit managers, and was more of a fact-finding mission on how these companies operate than a debate about policy proposals.
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don鈥檛 have to.
Rebecca Adams of CQ Roll Call, Anna Edney of Bloomberg News and Alice Miranda Ollstein of Politico join KHN鈥檚 Julie Rovner to discuss the latest 鈥渨ill they or won鈥檛 they?鈥� when it comes to Republicans and comprehensive health reform. Also, a wrap-up of the latest abortion fights in the states and on Capitol Hill. And, another court setback for the Trump administration鈥檚 efforts to undermine the Affordable Care Act. Plus, Rovner interviews KHN鈥檚 Paula Andalo about the latest 鈥淏ill of the Month鈥� feature.
漏 2026 KFF